Carl Goldfischer

Director, PONIARD PHARMACEUTICALS, INC.

Companies

Damora Therapeutics, Inc.Board member Oct 28, 2020 to now¹
Epizyme, Inc.Board member May 30, 2013 to Aug 16, 2022²
Enliven Therapeutics, Inc.Board member Mar 11, 2020 to Jun 3, 2022³
CymaBay Therapeutics (United States)Board member Oct 11, 2013 to Feb 8, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Enliven Therapeutics, Inc. ELVN703,380 shares⁵$27.0M at $38.33Jun 3, 2022
Epizyme, Inc.0 shares⁶Aug 12, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 12, 2022Returned to company 3,380,951 shares of Epizyme, Inc.⁶
Aug 12, 2022Returned to company 8,994 shares of Epizyme, Inc.⁶
Aug 12, 2022Returned to company 13,060 shares of Epizyme, Inc.⁶
May 17, 2022Granted 8,994 shares of Epizyme, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDamora Therapeutics, Inc., Board member
2
SEC EDGAREpizyme, Inc., Board member
3
SEC EDGAREnliven Therapeutics, Inc., Board member
4
SEC EDGARCymaBay Therapeutics (United States), Board member
5
SEC EDGAREnliven Therapeutics, Inc. shares after the filing of Jun 3, 2022
6
SEC EDGAREpizyme, Inc. shares after the filing of Aug 12, 2022
7
SEC EDGARForm 4 filed May 19, 2022